Only in a select group of colorectal cancer patients who have microsatellite instability which is about 5% of total patients. We know these tumors are incredibly reposnsive to immunotherapy. Great results though and is promising for that cohort. Dostarlimab is very similar to other immunotherapy agents like Keytruda, Opdivo, etcApparently a new drug Dostarlimab has shown great results in eradicating Colon Cancer and getting rid of solid tumors.
They did a trial with 12 participants and after 6 months and taking the medication every 3 weeks for that 6 months they all came back completely clear of cancer.
The study is published in the New England Journal of Medicine already.